We hypothesized that the combination therapy of IL‐33 and BTZ could significantly promote the generation of ROS, which induced MM cell death, in addition, excessive ROS accumulation attenuated the NF‐κB activity, thereby decreasing the stemness properties of MM cells. Here, NFKB1 is linked to Miyoshi myopathy.